Wegovy Linked to Higher Ischemic Optic Neuropathy Risk

New FAERS analysis finds Wegovy carries nearly fivefold higher ischemic optic neuropathy risk vs. Ozempic, raising ocular safety concerns for GLP-1 drugs.